Design and synthesis of novel 3,4-disubstituted pyrazoles for nanomedicine applications against malignant gliomas
Authors:
- Mauro Comes FranchiniMauro Comes Franchini
- Bianca Flavia BoniniBBBianca Flavia Bonini
- Carlo Maurizio CamaggiCCCarlo Maurizio Camaggi
- Denis GentiliDGDenis Gentili
- Annalisa PessionAPAnnalisa Pession
- Monica RaniMRMonica Rani
- Elena StrocchiESElena Strocchi
- 1 May 2010
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 45 (5) , 2024-2033
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticlesProceedings of the National Academy of Sciences, 2008
- Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology ConsortiumCancer, 2008
- Optimization of a Dihydropyrrolopyrazole Series of Transforming Growth Factor-β Type I Receptor Kinase Domain Inhibitors: Discovery of an Orally Bioavailable Transforming Growth Factor-β Receptor Type I Inhibitor as Antitumor AgentJournal of Medicinal Chemistry, 2008
- Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymersProceedings of the National Academy of Sciences, 2008
- Tetanus toxin C fragment-conjugated nanoparticles for targeted drug delivery to neuronsBiomaterials, 2007
- Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug deliveryBiomaterials, 2007
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences, 2006
- Nanotechnology, nanomedicine, and the development of new, effective therapies for cancerNanomedicine: Nanotechnology, Biology and Medicine, 2005
- Development of TGF-β signalling inhibitors for cancer therapyNature Reviews Drug Discovery, 2004
- Thioamides: Synthesis, Stability, and Immunological Activities of Thioanalogues of Imreg. Preparation of New Thioacylating Agents Using Fluorobenzimidazolone DerivativesJournal of Medicinal Chemistry, 1999